GetTopicDetailResponse(id=f06536499c1, topicName=卡塔爾, introduction=卡塔爾, content=null, image=null, comments=5, allHits=1300, url=https://h5.medsci.cn/topic?id=36499, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=7068, tagList=[TagDto(tagId=7068, tagName=卡塔爾)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1603952, encodeId=d4d61603952a1, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔爾#</a>, objectTitle=NEJM：BNT162b2疫苗對(duì)卡塔爾SARS-CoV-2感染的保護(hù)效應(yīng)減弱, objectType=article, longId=221776, objectId=0117221e7685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0117221e7685, replyNumber=0, likeNumber=84, createdTime=2021-12-11, rootId=0, userName=旅苦化文_214, userId=d37d19121627, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0117221e7685, moduleTitle=NEJM：BNT162b2疫苗對(duì)卡塔爾SARS-CoV-2感染的保護(hù)效應(yīng)減弱, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0117221e7685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔爾#</a>, objectTitle=2021年10月5日簡(jiǎn)報(bào)：歐洲藥管局批準(zhǔn)所有成人打輝瑞加強(qiáng)針；卡塔爾將中國(guó)新冠疫苗列入認(rèn)可疫苗清單；英國(guó)進(jìn)一步簡(jiǎn)化入境政策, objectType=article, longId=218138, objectId=076221813854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=076221813854, replyNumber=0, likeNumber=113, createdTime=2021-10-06, rootId=0, userName=旅苦化文_214, userId=d37d19121627, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=076221813854, moduleTitle=2021年10月5日簡(jiǎn)報(bào)：歐洲藥管局批準(zhǔn)所有成人打輝瑞加強(qiáng)針；卡塔爾將中國(guó)新冠疫苗列入認(rèn)可疫苗清單；英國(guó)進(jìn)一步簡(jiǎn)化入境政策, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=076221813854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1603950, encodeId=da801603950b3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔爾#</a>, objectTitle=Nat Commun：中東卡塔爾人群的全基因組關(guān)聯(lián)研究揭示45種臨床相關(guān)性狀的遺傳關(guān)聯(lián)性, objectType=article, longId=207936, objectId=332f20e9361c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=332f20e9361c, replyNumber=0, likeNumber=79, createdTime=2021-03-07, rootId=0, userName=旅苦化文_214, userId=d37d19121627, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=332f20e9361c, moduleTitle=Nat Commun：中東卡塔爾人群的全基因組關(guān)聯(lián)研究揭示45種臨床相關(guān)性狀的遺傳關(guān)聯(lián)性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=332f20e9361c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔爾#</a>, objectTitle=卡塔爾基金會(huì)的Sidra Medicine正式落成，開(kāi)啟醫(yī)療保健新時(shí)代, objectType=article, longId=153545, objectId=9a8a1535454b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a8a1535454b, replyNumber=0, likeNumber=92, createdTime=2018-11-16, rootId=0, userName=旅苦化文_214, userId=d37d19121627, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a8a1535454b, moduleTitle=卡塔爾基金會(huì)的Sidra Medicine正式落成，開(kāi)啟醫(yī)療保健新時(shí)代, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9a8a1535454b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1603948, encodeId=51d11603948fc, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔爾#</a>, objectTitle=巴斯德研究所和卡塔爾哈馬德-本-哈利法大學(xué)簽署諒解備忘錄, objectType=article, longId=115658, objectId=58c4115658f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c4115658f1, replyNumber=0, likeNumber=98, createdTime=2017-10-12, rootId=0, userName=旅苦化文_214, userId=d37d19121627, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c4115658f1, moduleTitle=巴斯德研究所和卡塔爾哈馬德-本-哈利法大學(xué)簽署諒解備忘錄, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=58c4115658f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
